Why the study?
Does intravenous infusion of angiotensin II activate platelets and coagulation in healthy males?
Does intravenous infusion of angiotensin II activate platelets and coagulation in healthy males?
Angiotensin II infusion in healthy males causes mild platelet activation and enhances coagulation, suggesting a potential prothrombotic effect.
Answers are grounded in this paper and cite their sources.
Ang II infusion may promote mild platelet activation in healthy males; hypothesis-generating for thrombotic risk in patients and requires confirmation.
The present study was undertaken to evaluate the effects of an intravenous infusion of angiotensin II (10 ng/kg per min) on platelet function and coagulation in vivo in 18 healthy males. The infusion increased mean arterial pressure by 23+/-2 mm Hg. Plasma beta-thromboglobulin levels, reflecting platelet secretion, increased by 66+/-24% during the infusion, as did also platelet surface expression of P-selectin as measured by flow cytometry. Platelet fibrinogen binding increased, whereas platelet aggregability, assessed by ex vivo filtragometry, was unaltered. Angiotensin II caused mild activation of the coagulation cascade with increases in plasma levels of thrombin-antithrombin complex and prothrombin fragment F1 + 2. In conclusion, angiotensin II has mild platelet-activating effects in vivo and also enhances coagulation. Markers of platelet secretion are significantly increased, whereas markers of platelet aggregability are less affected. The clinical relevance of these findings remains to be clarified.
No takes yet. Share an insight, caveat, or question.
Larsson et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: